These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 24481489)
1. In vitro and in vivo radiosensitization of human glioma U251 cells induced by upregulated expression of SLC22A18. Chu SH; Zhou ZM; Karri S; Li ZQ; Zhao JM Cancer Gene Ther; 2014 Mar; 21(3):103-9. PubMed ID: 24481489 [TBL] [Abstract][Full Text] [Related]
2. Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human glioma. Chu SH; Feng DF; Ma YB; Zhang H; Zhu ZA; Li ZQ; Jiang PC J Transl Med; 2011 Sep; 9():156. PubMed ID: 21936894 [TBL] [Abstract][Full Text] [Related]
3. Effect of 5-Aza-2'-deoxycytidine on SLC22A18 in glioma U251 cells. Chu SH; Ma YB; Feng DF; Zhang H; Qiu JH; Zhu ZA Mol Med Rep; 2012 Jan; 5(1):138-41. PubMed ID: 21993522 [TBL] [Abstract][Full Text] [Related]
4. PTEN expression in U251 glioma cells enhances their sensitivity to ionizing radiation by suppressing DNA repair capacity. Li HL; Wang CY; Fu J; Yang XJ; Sun Y; Shao YH; Zhang LH; Yang XM; Zhang XL; Lin J Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10453-10458. PubMed ID: 31841199 [TBL] [Abstract][Full Text] [Related]
5. Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy. Chu SH; Ma YB; Feng DF; Li ZQ; Jiang PC J Transl Med; 2013 Mar; 11():69. PubMed ID: 23514245 [TBL] [Abstract][Full Text] [Related]
6. Cathepsin L suppression increases the radiosensitivity of human glioma U251 cells via G2/M cell cycle arrest and DNA damage. Zhang QQ; Wang WJ; Li J; Yang N; Chen G; Wang Z; Liang ZQ Acta Pharmacol Sin; 2015 Sep; 36(9):1113-25. PubMed ID: 26095040 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene. Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid. Camphausen K; Cerna D; Scott T; Sproull M; Burgan WE; Cerra MA; Fine H; Tofilon PJ Int J Cancer; 2005 Apr; 114(3):380-6. PubMed ID: 15578701 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo radiosensitization induced by hydroxyapatite nanoparticles. Chu SH; Karri S; Ma YB; Feng DF; Li ZQ Neuro Oncol; 2013 Jul; 15(7):880-90. PubMed ID: 23519742 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of STAT3 and ErbB2 suppresses tumor growth, enhances radiosensitivity, and induces mitochondria-dependent apoptosis in glioma cells. Gao L; Li F; Dong B; Zhang J; Rao Y; Cong Y; Mao B; Chen X Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1223-31. PubMed ID: 20610043 [TBL] [Abstract][Full Text] [Related]
11. Hydroxyapatite nanoparticles inhibit the growth of human glioma cells in vitro and in vivo. Chu SH; Feng DF; Ma YB; Li ZQ Int J Nanomedicine; 2012; 7():3659-66. PubMed ID: 22888225 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of SATB1 is associated with the development and progression of glioma. Chu SH; Ma YB; Feng DF; Zhang H; Zhu ZA; Li ZQ; Jiang PC J Transl Med; 2012 Jul; 10():149. PubMed ID: 22839214 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-153-3p enhances cell radiosensitivity by targeting BCL2 in human glioma. Sun D; Mu Y; Piao H Biol Res; 2018 Dec; 51(1):56. PubMed ID: 30537994 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor. Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107 [TBL] [Abstract][Full Text] [Related]
15. Elevated expression of solute carrier family 22 member 18 increases the sensitivity of U251 glioma cells to BCNU. Chu SH; Ma YB; Feng DF; Zhang H; Qiu JH; Zhu ZA Oncol Lett; 2011 Nov; 2(6):1139-1142. PubMed ID: 22848278 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomide. Kil WJ; Cerna D; Burgan WE; Beam K; Carter D; Steeg PS; Tofilon PJ; Camphausen K Clin Cancer Res; 2008 Feb; 14(3):931-8. PubMed ID: 18245557 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of secreted protein acidic and rich in cysteine (SPARC) expression diminishes radiosensitivity of glioma cells. Liu H; Zhang H; Jiang X; Ma Y; Xu Y; Feng S; Liu F Cancer Biother Radiopharm; 2011 Dec; 26(6):705-15. PubMed ID: 22145659 [TBL] [Abstract][Full Text] [Related]
18. Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102. Buchanan IM; Scott T; Tandle AT; Burgan WE; Burgess TL; Tofilon PJ; Camphausen K J Cell Mol Med; 2011 Sep; 15(9):1999-2006. PubMed ID: 20629992 [TBL] [Abstract][Full Text] [Related]
19. Silencing of the TPM1 gene induces radioresistance of glioma U251 cells. Du HQ; Wang Y; Jiang Y; Wang CH; Zhou T; Liu HY; Xiao H Oncol Rep; 2015 Jun; 33(6):2807-14. PubMed ID: 25873252 [TBL] [Abstract][Full Text] [Related]
20. Correlation of low SLC22A18 expression with poor prognosis in patients with glioma. Chu SH; Ma YB; Feng DF; Zhang H; Zhu ZA; Li ZQ; Jiang PC J Clin Neurosci; 2012 Jan; 19(1):95-8. PubMed ID: 22153794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]